top of page

Poster 51

Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: Evaluation of Creatine Phosphokinase Elevations in the Phase 3 POETYK PSO-1 and PSO-2 Trials


Authors: Mark Lebwohl, Bruce Strober, Thomas Scharnitz, Misti Linaberry, Kim Hoyt, Subhashis Banerjee, Renata M. Kisa, George Martin



POSTER 51

21 views0 comments

Comments


QUESTIONS, COMMENTS, & SURVEY

Please Rate This PosterPoorFairGoodVery goodExcellentPlease Rate This Poster
Thank you for submitting your feedback!

Search by Poster Number

bottom of page